TREM2 and the neuroimmunology of Alzheimer's disease

Biochemical Pharmacology

Volumn 88, Issue 4, 2014, Pages 495-498

  Hickman, Suzanne E ^a   El Khoury, Joseph ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Microglia; NeuroImmunology; TREM2

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; GAMMA INTERFERON; INTERLEUKIN 1BETA; MEMBRANE RECEPTOR; NEUROTOXIN; PRESENILIN 1; PRESENILIN 2; REACTIVE OXYGEN METABOLITE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLELE; ALZHEIMER DISEASE; ARTICLE; BONE MARROW CELL; DISEASE COURSE; DOWN REGULATION; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; MICROGLIA; MONONUCLEAR PHAGOCYTE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RISK FACTOR; UPREGULATION;

ALZHEIMER'S DISEASE; MICROGLIA; NEUROIMMUNOLOGY; TREM2;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE GLYCOPROTEINS; MICROGLIA; PHAGOCYTES; RECEPTORS, IMMUNOLOGIC; RISK FACTORS;

EID: 84897954222     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.11.021     Document Type: Article

References (48)

1. D.J. Selkoe The molecular pathology of Alzheimer's disease Neuron 6 1991 487 498
2. C. Qiu, M. Kivipelto, and E. von Strauss Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention Dialogues Clin Neurosci 11 2009 111 128
3. M. Cruts, J. Theuns, and C. Van Broeckhoven Locus-specific mutation databases for neurodegenerative brain diseases Hum Mutat 33 2012 1340 1344
4. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, and S. Younkin et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102 (Pubitemid 26332733)
5. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, and R. Kayed et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421 (Pubitemid 36937044)
6. J.L. Jankowsky, H.H. Slunt, T. Ratovitski, N.A. Jenkins, N.G. Copeland, and D.R. Borchelt Co-expression of multiple transgenes in mouse CNS: a comparison of strategies Biomol Eng 17 2001 157 165 (Pubitemid 32409891)
7. L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, and P. Jantzen et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nat Med 4 1998 97 100 (Pubitemid 28133087)
8. L. Bertram, C.M. Lill, and R.E. Tanzi The genetics of Alzheimer disease: back to the future Neuron 68 2010 270 281
9. R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, and E. Majounie et al. TREM2 variants in Alzheimer's disease New Engl J Med 368 2013 117 127
10. T. Jonsson, H. Stefansson, S. Steinberg, I. Jonsdottir, P.V. Jonsson, and J. Snaedal et al. Variant of TREM2 associated with the risk of Alzheimer's disease New Engl J Med 368 2013 107 116
11. F. Ozsolak, A. Goren, M. Gymrek, M. Guttman, A. Regev, and B.E. Bernstein et al. Digital transcriptome profiling from at to mole-level RNA samples Genome Res 20 2010 519 525
12. F. Ozsolak, P. Kapranov, S. Foissac, S.W. Kim, E. Fishilevich, and A.P. Monaghan et al. Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation Cell 143 2010 1018 1029
13. F. Ozsolak, A.R. Platt, D.R. Jones, J.G. Reifenberger, L.E. Sass, and P. McInerney et al. Direct RNA sequencing Nature 461 2009 814 818
14. F. Ozsolak, D.T. Ting, B.S. Wittner, B.W. Brannigan, S. Paul, and N. Bardeesy et al. Amplification-free digital gene expression profiling from minute cell quantities Nat Methods 7 2010 619 621
15. S.E. Hickman, N.D. Kingery, T.K. Ohsumi, M.L. Borowsky, L.C. Wang, and T.K. Means et al. The microglial sensome revealed by direct RNA sequencing Nat Neurosci 16 2013 1896 1905
16. H. Kettenmann, U.K. Hanisch, M. Noda, and A. Verkhratsky Physiology of microglia Physiol Rev 91 2011 461 553
17. J. El Khoury, and A.D. Luster Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications Trends Pharmacol Sci 29 2008 626 632
18. J. El Khoury, M. Toft, S.E. Hickman, T.K. Means, K. Terada, and C. Geula et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease Nat Med 13 2007 432 438 (Pubitemid 46559828)
19. J.B. El Khoury, K.J. Moore, T.K. Means, J. Leung, K. Terada, and M. Toft et al. CD36 mediates the innate host response to beta-amyloid J Exp Med 197 2003 1657 1666 (Pubitemid 36745341)
20. S.E. Hickman, E.K. Allison, and J. El Khoury Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice J Neurosci 28 2008 8354 8360
21. S.E. Hickman, and J. El Khoury The neuroimmune system in Alzheimer's disease: the glass is half full J Alzheimer's Dis 33 Suppl 1 2013 S295 S302
22. J. El Khoury Neurodegeneration and the neuroimmune system Nat Med 16 2010 1369 1370
23. J. El Khoury, S.E. Hickman, C.A. Thomas, L. Cao, S.C. Silverstein, and J.D. Loike Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils Nature 382 1996 716 719 (Pubitemid 26282177)
24. J. El Khoury, S.E. Hickman, C.A. Thomas, J.D. Loike, and S.C. Silverstein Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease Neurobiol Aging 19 1998 S81 S84
25. D. Frenkel, K. Wilkinson, L. Zhao, S.E. Hickman, T.K. Means, and L. Puckett et al. Scara1 deficiency impairs clearance of soluble amyloid-beta by mononuclear phagocytes and accelerates Alzheimer's-like disease progression Nat Commun 4 2013 2030
26. D. Frenkel, L. Puckett, S. Petrovic, W. Xia, G. Chen, and J. Vega et al. A nasal proteosome adjuvant activates microglia and prevents amyloid deposition Ann Neurol 63 2008 591 601
27. C.R. Stewart, L.M. Stuart, K. Wilkinson, J.M. van Gils, J. Deng, and A. Halle et al. CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer Nat Immunol 11 2010 155 161
28. W.P. Esler, and M.S. Wolfe A portrait of Alzheimer secretases - new features and familiar faces Science 293 2001 1449 1454 (Pubitemid 32801541)
29. Y.F. Liao, B.J. Wang, H.T. Cheng, L.H. Kuo, and M.S. Wolfe Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway J Biol Chem 279 2004 49523 49532 (Pubitemid 39625840)
30. H.S. Hong, E.M. Hwang, H.J. Sim, H.J. Cho, J.H. Boo, and S.S. Oh et al. Interferon gamma stimulates beta-secretase expression and sAPPbeta production in astrocytes Biochem Biophys Res Commun 307 2003 922 927 (Pubitemid 36871661)
31. I. Blasko, R. Veerhuis, M. Stampfer-Kountchev, M. Saurwein-Teissl, P. Eikelenboom, and B. Grubeck-Loebenstein Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes Neurobiol Dis 7 2000 682 689 (Pubitemid 32044292)
32. M.T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, I. Dewachter, J. Walter, and T. Klockgether et al. Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice J Neuroinflamm 2 2005 22
33. M. Sastre, I. Dewachter, G.E. Landreth, T.M. Willson, T. Klockgether, and F. van Leuven et al. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase J Neurosci 23 2003 9796 9804 (Pubitemid 37371592)
34. Q. Yan, J. Zhang, H. Liu, S. Babu-Khan, R. Vassar, and A.L. Biere et al. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease J Neurosci 23 2003 7504 7509 (Pubitemid 37034066)
35. M.T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, A. Hanke, I. Dewachter, and C. Kuiperi et al. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice Brain 128 2005 1442 1453 (Pubitemid 40826196)
36. M. Sastre, I. Dewachter, S. Rossner, N. Bogdanovic, E. Rosen, and P. Borghgraef et al. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma PNAS 103 2006 443 448 (Pubitemid 43122420)
37. M.R. Daws, L.L. Lanier, W.E. Seaman, and J.C. Ryan Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family Eur J Immunol 31 2001 783 791 (Pubitemid 32237115)
38. J.A. Hamerman, J.R. Jarjoura, M.B. Humphrey, M.C. Nakamura, W.E. Seaman, and L.L. Lanier Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12 J Immunol 177 2006 2051 2055 (Pubitemid 44200961)
39. I.R. Turnbull, S. Gilfillan, M. Cella, T. Aoshi, M. Miller, and L. Piccio et al. Cutting edge: TREM-2 attenuates macrophage activation J Immunol 177 2006 3520 3524 (Pubitemid 44359882)
40. H. Ito, and J.A. Hamerman TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells Eur J Immunol 42 2012 176 185
41. K. Takahashi, C.D. Rochford, and H. Neumann Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 J Exp Med 201 2005 647 657 (Pubitemid 40289554)
42. C.L. Hsieh, M. Koike, S.C. Spusta, E.C. Niemi, M. Yenari, and M.C. Nakamura et al. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia J Neurochem 109 2009 1144 1156
43. E.N. N'Diaye, C.S. Branda, S.S. Branda, L. Nevarez, M. Colonna, and C. Lowell et al. TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria J Cell Biol 184 2009 215 223
44. L. Stefano, G. Racchetti, F. Bianco, N. Passini, R.S. Gupta, and P. Panina Bordignon et al. The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor J Neurochem 110 2009 284 294
45. J. Paloneva, T. Manninen, G. Christman, K. Hovanes, J. Mandelin, and R. Adolfsson et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype Am J Hum Genet 71 2002 656 662 (Pubitemid 34970138)
46. R.J. Guerreiro, E. Lohmann, J.M. Bras, J.R. Gibbs, J.D. Rohrer, and N. Gurunlian et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement JAMA Neurol 70 2013 78 84
47. D. Centonze, L. Muzio, S. Rossi, F. Cavasinni, V. De Chiara, and A. Bergami et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis J Neurosci 29 2009 3442 3452
48. S. Frank, G.J. Burbach, M. Bonin, M. Walter, W. Streit, and I. Bechmann et al. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice Glia 56 2008 1438 1447